- Home
- VTAK vs SXTC Comparison
VTAK vs SXTC Comparison
Compare VTAK & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTAK
- SXTC
- Stock Information
- Founded
- VTAK 2002
- SXTC 2005
- Country
- VTAK United States
- SXTC China
- Employees
- VTAK N/A
- SXTC N/A
- Industry
- VTAK Medical/Dental Instruments
- SXTC Biotechnology: Pharmaceutical Preparations
- Sector
- VTAK Health Care
- SXTC Health Care
- Exchange
- VTAK Nasdaq
- SXTC Nasdaq
- Market Cap
- VTAK 1.4M
- SXTC 1.6M
- IPO Year
- VTAK 2018
- SXTC 2019
- Fundamental
- Price
- VTAK $0.33
- SXTC $0.32
- Analyst Decision
- VTAK
- SXTC
- Analyst Count
- VTAK 0
- SXTC 0
- Target Price
- VTAK N/A
- SXTC N/A
- AVG Volume (30 Days)
- VTAK 152.4K
- SXTC 1.7M
- Earning Date
- VTAK 11-13-2024
- SXTC 01-01-0001
- Dividend Yield
- VTAK N/A
- SXTC N/A
- EPS Growth
- VTAK N/A
- SXTC N/A
- EPS
- VTAK N/A
- SXTC N/A
- Revenue
- VTAK $399,000.00
- SXTC $1,928,497.00
- Revenue This Year
- VTAK $637.10
- SXTC N/A
- Revenue Next Year
- VTAK $177.13
- SXTC N/A
- P/E Ratio
- VTAK N/A
- SXTC N/A
- Revenue Growth
- VTAK 27.07
- SXTC N/A
- 52 Week Low
- VTAK $0.31
- SXTC $0.30
- 52 Week High
- VTAK $4.10
- SXTC $6.39
- Technical
- Relative Strength Index (RSI)
- VTAK 34.81
- SXTC 33.98
- Support Level
- VTAK $0.31
- SXTC $0.39
- Resistance Level
- VTAK $0.37
- SXTC $0.36
- Average True Range (ATR)
- VTAK 0.04
- SXTC 0.05
- MACD
- VTAK 0.00
- SXTC -0.00
- Stochastic Oscillator
- VTAK 20.00
- SXTC 7.97
About VTAK Catheter Precision Inc.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.